FDA re­leas­es PDU­FA VI pro­gram re­port on com­bi­na­tion prod­ucts

A new in­de­pen­dent re­port on the FDA’s re­view prac­tices for com­bi­na­tion prod­ucts un­der the Pre­scrip­tion Drug User Fee Act (PDU­FA VI) gives the agency gen­er­al­ly …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER